PANASONIC
1.7.2020 12:02:06 CEST | Business Wire | Press release
Panasonic is proud to announce the start of its innovative, CO2 -saving energy solution for the smart city project, Future Living® Berlin. The urban beacon is an important project in the company’s wider smart cities portfolio, which contribute to its focus on the decarbonization of society.
The installation in Berlin combines both green & sustainable and digital & connected living. It is realised through the installation of smart energy solutions including Panasonic’s highly efficient air to water heat pumps, photovoltaic (PV) panels and storage batteries integrated into an intelligent and efficient energy management system.
Junichi Suzuki, Chairman and CEO of Panasonic Europe B.V comments,
‘We bring to the project over 60 years of heating and cooling expertise alongside decades in PV and battery solutions, and a passion for innovations that will shape the future for generations to come. ‘
Panasonic has achieved strong sales growth in the relevant Energy business areas in Europe, e.g. double-digit sales growth in the air to water heat pump business for the last 10 years. The company has also committed in 2019 to grow the “Residential Energy Saving Equipment” business multiple times over by 2025.
Efficient Energy Management
For Panasonic, Future Living® Berlin is a fundamentally important experiment in building cutting-edge energy solutions. The project marks a milestone in achieving the goals set in the strategy.
Panasonic’s energy experts and software engineers of its R&D Centre in Europe have developed an intelligent energy management solution to optimize the use of energy and couple electricity with the heating sector. The smart control combines heat pumps together with other efficient, green Panasonic technologies, such as PV panels. The technologies have been integrated into an efficient energy saving solution not only controlled, but also constantly optimised by Panasonic’s intelligent energy management solution.
Ralf Becker, Project Leader Energy Group, Panasonic R&D Centre Europe explains,
‘The solution is a world first, developed with leading research institutions for decentralized energy management. In simulations together with university test labs we achieved an improvement of used energy by up to 15%.‘
A Beacon for Sustainable Living
The core energy component of the Future Living Berlin green & sustainable goal is the installed Panasonic’s air to water heat pump product line-up, ‘Aquarea’. A highly energy efficient technology, they run almost carbon-free when powered by the renewable energy provided by the 600 Panasonic HIT panels, which supply a capacity of 195kWp. On account of the patented silicone technology, the Panasonic photovoltaic system is 10% more efficient than conventional modules. Furthermore Panasonic’s HIT technology achieves a significantly better performance in hot environments because of its superior temperature coefficient – an essential advantage in coping with the climate change.
Utilising the renewable energy, the air to water system is used for space heating and warm water generation. For increased performance, the heat pumps include a cloud-based connectivity feature for installers called Aquarea Service Cloud which makes them even more reliable. It saves further CO2 emissions as maintenance visits can be organized much more efficiently and partly even conducted remotely.
These energy solutions are brought together under a Aquarea Smart Cloud, which allows end-users to monitor their power usage and manage temperature settings accordingly. This results in increased efficiency and comfort while enjoying transparency of their consumption.
To achieve further sustainable and green objectives, residents are part of a wider ecological environment which offers green car sharing, shared washing machines, and Panasonic energy solutions
Connected comfortability
The digital & connected goal of Future Living Berlin starts within the residential apartments. The equipment follows the idea of being smart and connected with Panasonic TVs and smart speakers being part of an overall IoT infrastructure, which includes an apartment manager as the central hub.
Digital & connected solutions are further extended to include wider security, safety, and smart building solutions that enhance the overall comfortability of residents.
Suzuki continues,
‘Future Living® Berlin is a future Way of Living – of how we may live tomorrow with a focus on social, digital & connected, and green & sustainable living.’
Panasonic is partnering in the smart city project with GSW Sigmaringen, the building-owner of Future Living® Berlin.
About Panasonic
Panasonic Corporation is a global leader developing innovative technologies and solutions for wide-ranging applications in the consumer electronics, housing, automotive, and B2B sectors. The company, which celebrated its 100th anniversary in 2018, operates 528 subsidiaries and 72 associated companies worldwide and reported consolidated net sales of 61.9 billion Euro (7.49 trillion yen) for the year ended March 31, 2020. Committed to pursuing new value through collaborative innovation, the company uses its technologies to create a better life and a better world for customers. To learn more about Panasonic: https://www.panasonic.com/global
IMAGES TO DOWNLOAD: https://www.flickr.com/photos/panasonic-europe/collections/72157714840244853/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005388/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
